Tulyp Medical
Tulyp Medical is a Paris-based privately held, medical device company and part of Sofinnova MD Start, Sofinnova Partners' medical device accelerator. The company is developing a patented pressure-driven perfusion system for vascular procedures. Based on the fundamental principle that oxygen delivery is governed by vascular pressure rather than flow, Tulyp’s technology is designed to improve tissue oxygenation and reduce complications in patients undergoing major interventions.
Sector
Medical Devices
Location
Paris
Strategies
MD Start
Status
Live
Website
LinkedIn
SofinnovaCapital
The Sofinnova Capital Strategy acts as a founding and lead investor in early-stage biopharma and medtech start-ups focusing on groundbreaking therapeutic technologies.
SofinnovaMD Start
The MD Start Strategy is Sofinnova’s in-house medtech accelerator. The team’s hands-on entrepreneurial expertise contributes to the platform's global leadership in company building.
SofinnovaCrossover
The Sofinnova Crossover Strategy supports ground-breaking innovations in later-stage biotech and medtech companies, enabling ambitious life sciences companies to reach their full potential.
SofinnovaIndustrial Biotech
Our Industrial Biotech Strategy seeks early-stage investments that will have a positive impact on sustainability in the chemicals, agriculture, food and materials sectors.
SofinnovaTelethon
The Sofinnova Telethon Strategy seeks early-stage projects to bring the best Italian science to the world stage.
SofinnovaDigital Medicine
The Sofinnova Digital Medicine Strategy backs early-stage startups at the intersection of biology, data and computation.
SofinnovaBiovelocita
The Sofinnova Biovelocita Strategy is dedicated entirely to the creation and acceleration of European biotech startups, in partnership with leading research organizations.